This is a prospective, randomized, two-arm, controlled 30-day investigational pilot trial using the gammaCore Sapphire S non-invasive vagus nerve stimulation (nVNS) device + standard of care (SOC) in newly-hospitalized patients with mild-to-moderate traumatic brain injury (TBI) to prevent the progression towards immunokine storms, systemic inflammatory response syndrome (SIRS), severe respiratory distress, and requirement for invasive mechanical ventilation, and death, when compared to SOC alone (the control arm).
A pilot population of 46 individuals between 18-80 years of age inclusive, will be enrolled, with an in-trial monitoring period of up to 30 days following baseline measurements. Study subjects will remain in-trial until one of the following occurs: a) 30 days without any progression to respiratory distress requiring mechanical ventilation; b) requirement for mechanical ventilation prior to 30 days; or c) death prior to 30 days. In addition to the screening, a total of up to 5 additional in-trial events (depending on the time at discharge from hospitalization) plus one additional clinical site visit at the end of the follow-up period will comprise the study events schedule of this trial.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
3
AHN Allegheny General Hospital
Pittsburgh, Pennsylvania, United States
All-Cause 90-Day Admission to Any Hospital or ED Encounter
A composite endpoint of 90-day presentation to any emergency department and/or 90-day admission to any hospital.
Time frame: 90 days
Number of Participants With AEs/SAEs Up to 30 Days From Baseline
Time frame: 30 days from baseline
Number of Participants With Abnormal Physical Examination by Day 30
Time frame: 30 days from baseline
Number of Participants With Abnormal Vital Signs by Day 30
Time frame: 30 days from baseline
Number of Participants With Abnormal Laboratory Results by Day 30
Time frame: 30 days from baseline
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.